The pharmaceutically acceptable salts of bicycle-substituted pyrazolon azoderivativesrepresented by the general formula (I), their preparation methods,pharmaceuticalcompositions containing the same and their use as a therapeutic agent,especially asthrombopoietin (TPO) mimetics and their use as agonists of thrombopoietinreceptor.The definitions of substituents in the general formula (I) are the same as thedescription.(see formula I)
